Transbrachial and transfemoral approaches combined with visceral protection for the treatment of juxtarenal aortoiliac occlusive disease: Technical issues and clinical outcomes

Abstract

Purpose

To evaluate the safety and efficacy of transbrachial and transfemoral approaches combined with visceral protection for the endovascular treatment of juxtarenal aortoiliac occlusive disease (AIOD) over an average 19-month follow-up period.

Methods

In this retrospective analysis, all patients with juxtarenal AIOD at a single institution were reviewed from June 2015 to January 2020. Patient characteristics, angiographic results, and follow-up outcomes were retrospectively recorded. The indications for treatment were critical limb threatening ischemia in 12 patients and bilateral claudication in five patients. Percutaneous access via the left brachial artery was first obtained to recanalize the infrarenal occluded lesions. After that, femoral accesses were achieved. A 4-Fr catheter, a 4 mm balloon, or a 6-Fr 90-cm-long sheath was used to complete visceral artery protection.

Results

A total of 17 juxtarenal AIOD patients (14 males; mean age, 63.4 ± 8.1 years) underwent endovascular treatment. The technical success rate was 100%. Complete reconstruction was achieved in 15 (88.2%) patients. The infrarenal aorta was reconstructed with kissing covered stent grafts (n = 7), kissing bare-metal stents (n = 2), covered stent grafts (n = 2), bare-metal stents (n = 1), or the off-label use of iliac limb stent grafts (n = 5). Renal embolization was found in 3 (17.6%) patients during intraoperative angiography. There was 1 (5.9%) case of distal runoff embolization after CDT and 1 (5.9%) case of left iliac artery rupture. One (5.9%) death occurred due to acute myocardial infarction 20 days after the operation. The average follow-up period was 19.3 ± 16.7 months (range, 1–54 months) in the remaining 16 cases. The renal artery patency rate was 100%. The estimated cumulative primary patency rates were 92.3% at 12 months and 59.3% at 36 months according to the Kaplan–Meier method.

Conclusions

Transbrachial and transfemoral approaches combined with visceral protection offer a safe and effective alternative to open revascularization for the endovascular treatment of juxtarenal AIOD.

Keywords

Juxtarenal aortoiliac occlusive disease endovascular treatment transbrachial transfemoral visceral protection

Get full access to this article

View all access options for this article.

References

Fang

Lai

Qiu

, et al. Endovascular treatment for infrarenal aortic occlusion: a systematic review and meta-analysis. Ann Vasc Surg 2020; 62: 432–441 e413.

Bracale

Giribono

Spinelli

. Long-term results of endovascular treatment of TASC C and D aortoiliac occlusive disease with expanded polytetrafluoroethylene stent graft. Ann Vasc Surg 2019; 56: 254–260.

Marrocco-Trischitta

Bertoglio

Tshomba

, et al. The best treatment of juxtarenal aortic occlusion is and will be open surgery. J Cardiovasc Surg (Torino) 2012; 53: 307–312.

Saadeddin

Rybin

Doros

, et al. Comparison of early and late post-operative outcomes after supra-inguinal bypass for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 2019; 58: 529–537.

Sharma

Scully

Shah

, et al. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 2018; 68: 1796–1804 e1792.

Mangialardi

Ronchey

Serrao

, et al. Endovascular management of total juxtarenal aortic occlusive disease in high-risk patients: technical considerations and clinical outcome. J Cardiovasc Surg (Torino) 2017; 58: 422–430.

Pearce

Jr Yang

Shi

, et al. Circumferential aortic endarterectomy followed with immediate infrarenal clamping obviates suprarenal clamping for juxtarenal aortoiliac occlusion. Ann Vasc Surg 2016; 34: 48–54.

Conte

Bradbury

Kolh

, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg 2019; 69: 3S–125S e140.

Piffaretti

Fargion

Dorigo

, et al. Outcomes from the multicenter Italian registry on primary endovascular treatment of aortoiliac occlusive disease. J Endovasc Ther 2019; 26: 623–632.

10.

Sirignano

Mansour

Capoccia

, et al. Results of AFX unibody stent-graft implantation in patients with TASC D aortoiliac lesions and coexistent abdominal aortic aneurysms. J Endovasc Ther 2017; 24: 846–851.

11.

Taeymans

Groot Jebbink

Holewijn

, et al. Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease. J Vasc Surg 2018; 67: 1438–1447.

12.

Tatiana

Peter

, et al. Aortic stenting in symptomatic infrarenal aortic stenosis and subtotal aortic occlusion. Vasc Endovascular Surg 2019; 53: 303–309.

13.

Van Haren

Goldstein

Velazquez

, et al. Endovascular treatment of TransAtlantic Inter-Society Consensus D aortoiliac occlusive disease using unibody bifurcated endografts. J Vasc Surg 2017; 65: 398–405.

14.

Yuan

Bao

Zhao

, et al. Endovascular therapy for long-segment atherosclerotic aortoiliac occlusion. J Vasc Surg 2014; 59: 663–668.

15.

Groot Jebbink

Ter Mors

Slump

, et al. In vivo geometry of the kissing stent and covered endovascular reconstruction of the aortic bifurcation configurations in aortoiliac occlusive disease. Vascular 2017; 25: 635–641.

16.

Kretschmann

Usai

Taneva

, et al. The role of open and endovascular treatment of patients with chronic aortoiliac Leriche syndrome. Vascular 2020; 28: 68–73.

17.

Morisaki

Yamaoka

Iwasa

, et al. Outcomes of endovascular therapy for infrarenal aortic occlusion of TASC II D classification. Ann Vasc Surg 2017; 43: 203–209.

18.

Bin Jabr

Sonesson

Lindblad

, et al. Chimney grafts preserve visceral flow and allow safe stenting of juxtarenal aortic occlusion. J Vasc Surg 2013; 57: 399–405.

19.

Zamor

Hoel

Helenowski

, et al. Comparison of direct and less invasive techniques for the treatment of severe aorto-iliac occlusive disease. Ann Vasc Surg 2018; 46: 226–233.

20.

Samson

Showalter

Lepore

Jr , et al. Improved patency after axillofemoral bypass for aortoiliac occlusive disease. J Vasc Surg 2018; 68: 1430–1437.

21.

Kasahara

Shimizu

Yozu

. Postoperative renal function after juxtarenal aortic aneurysm repair with simple cross-clamping. Ann Vasc Surg 2013; 27: 291–298.

22.

Reijnen

. Update on covered endovascular reconstruction of the aortic bifurcation. Vascular 2020; 28: 225–232.

23.

Yuan

Bao

Zhao

, et al. Transbrachial and femoral artery approach endovascular therapy for flush infrarenal aortic occlusion. Eur J Vasc Endovasc Surg 2014; 48: 46–52.

24.

Martinez

Rodriguez-Lopez

Diethrich

. Stenting for abdominal aortic occlusive disease. Long-term results. Tex Heart Inst J 1997; 24: 15–22.

25.

de Donato

Pasqui

Setacci

, et al. Acute on chronic limb ischemia: from surgical embolectomy and thrombolysis to endovascular options. Semin Vasc Surg 2018; 31: 66–75

26.

Laird

Zeller

Holden

, et al. Balloon-expandable vascular covered stent in the treatment of iliac artery occlusive disease: 9-month results from the BOLSTER multicenter study. J Vasc Interv Radiol 2019; 30: 836–844 e831.

27.

Humphries

Armstrong

Laird

, et al. Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease. J Vasc Surg 2014; 60: 337–343.

28.

Goverde

Grimme

Verbruggen

, et al. Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease. J Cardiovasc Surg (Torino) 2013; 54: 383–387.

29.

Groot Jebbink

Mathai

Boersen

, et al. Hemodynamic comparison of stent configurations used for aortoiliac occlusive disease. J Vasc Surg 2017; 66: 251–260 e251.

30.

Groot Jebbink

Engelhard

Lajoinie

, et al. Influence of iliac stenotic lesions on blood flow patterns near a covered endovascular reconstruction of the aortic bifurcation (CERAB) stent configuration. J Endovasc Ther 2017; 24: 800–808.

31.

Dijkstra

Goverde

Holden

, et al. Initial experience with covered endovascular reconstruction of the aortic bifurcation in conjunction with chimney grafts. J Endovasc Ther 2017; 24: 19–24.